86 related articles for article (PubMed ID: 7867873)
21. Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am Heart J; 1989 Nov; 118(5 Pt 2):1127-8. PubMed ID: 2530871
[No Abstract] [Full Text] [Related]
22. Amlodipine versus nadolol in patients with stable angina pectoris.
Singh S; Doherty J; Udhoji V; Smith K; Gorwit J; Bekheit S; Mather S; Stein W; San Fellippo J; Hearan P
Am Heart J; 1989 Nov; 118(5 Pt 2):1137-8. PubMed ID: 2530878
[No Abstract] [Full Text] [Related]
23. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
[TBL] [Abstract][Full Text] [Related]
24. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH
J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287
[TBL] [Abstract][Full Text] [Related]
25. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
26. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
Brun J
J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
[TBL] [Abstract][Full Text] [Related]
27. Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study.
Thadani U
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S114. PubMed ID: 2467120
[No Abstract] [Full Text] [Related]
28. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
29. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
30. A review of amlodipine in myocardial ischaemia.
Taylor SH
Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
[TBL] [Abstract][Full Text] [Related]
31. A double-blind evaluation of amlodipine in patients with chronic, stable angina: sustained efficacy and lack of "withdrawal phenomenon" upon abrupt discontinuation.
Mehta JL; Lopez LM
Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III17-22. PubMed ID: 9156956
[TBL] [Abstract][Full Text] [Related]
32. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard.
Bremner AD; Fell PJ; Hosie J; James IG; Saul PA; Taylor SH
J Hum Hypertens; 1993 Feb; 7(1):79-81. PubMed ID: 8450526
[TBL] [Abstract][Full Text] [Related]
33. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
[TBL] [Abstract][Full Text] [Related]
34. Amlodipine versus nifedipine retard in the treatment of chronic ischemic heart disease.
Circo A; Scaccianoce G; Platania F; Castelli D; Cardillo R; Mangiameli S
Clin Ter; 1992 Jan; 140(1):43-57. PubMed ID: 1388115
[TBL] [Abstract][Full Text] [Related]
35. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
[TBL] [Abstract][Full Text] [Related]
37. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
Kinnard DR; Harris M; Hossack KF
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119
[TBL] [Abstract][Full Text] [Related]
38. Double-blind comparison between nifedipine and amlodipine for the treatment of essential hypertension.
Cappuccio FP; Markandu ND; Singer DR; Crane M; Carney C; MacGregor GA
J Hum Hypertens; 1993 Aug; 7(4):365-8. PubMed ID: 8410927
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
[TBL] [Abstract][Full Text] [Related]
40. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
de Vries RJ; Dunselman PH
Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
